Global Cord Blood Operating Income

Global Cord Blood (CO) currently reports a operating income of $590M as of July 2022. That compares with $570M in the prior-year period — up 4.7% year over year. Use the charts on this page to explore Global Cord Blood's operating income history and peer comparisons.

Global Cord Blood's operating income increased from $570M to $590M — a 4.7% year-over-year increase (period ending July 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Global Cord Blood reported $590M in operating income as of July 2022. That compares with $570M in the prior-year period — up 4.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $590M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Global Cord Blood, and consider following CO for alerts when major investors trade the stock.

Global Cord Blood is classified in the Healthcare sector. On operating income, it currently shows $590M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CO with unrelated industries.